Citation Impact
Citing Papers
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Detection and Quantification of Left Atrial Structural Remodeling With Delayed-Enhancement Magnetic Resonance Imaging in Patients With Atrial Fibrillation
2009
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants
2016 Standout
Adults with genetic syndromes and cardiovascular abnormalities: clinical history and management
2008
Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network
2018 Standout
Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment
2011
What's in a Name? Patients’ Preferred Terms for Describing Obesity
2003
Minimally invasive surgical ablation of atrial fibrillation: Six-month results
2009
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Five-Year Outcomes After Segmental Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation
2009
Effect of Internet Support on the Long‐Term Maintenance of Weight Loss
2004
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
Predictors and Risk of Ventricular Tachyarrhythmias or Death in Black and White Cardiac Patients
2016
Current and Investigational Antiobesity Agents and Obesity Therapeutic Treatment Targets
2004
Long‐Term Outcome of Atrial Fibrillation Ablation: Impact and Predictors of Very Late Recurrence
2010
State‐Level Estimates of Annual Medical Expenditures Attributable to Obesity*
2004
TGFβ signalling in context
2012 Standout
Mechanotransduction and extracellular matrix homeostasis
2014 Standout
Is There a Lag Globally in Overweight Trends for Children Compared with Adults?
2006
Heterogeneous Expression of Potassium Currents and Pacemaker Currents Potentially Regulates Arrhythmogenesis of Pulmonary Vein Cardiomyocytes
2009
Exercise Standards for Testing and Training
2013 Standout
Using Pedometers to Increase Physical Activity and Improve Health
2007 Standout
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Fibrillin‐rich microfibrils: Structural determinants of morphogenetic and homeostatic events
2007
TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves
2013
Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation—Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
2015
Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation
2012
Familial thoracic aortic dilation and bicommissural aortic valve: A prospective analysis of natural history and inheritance
2007
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
2013
Diagnostic Utility of a Novel Leadless Arrhythmia Monitoring Device
2013
Primary Care Physicians’ Attitudes about Obesity and Its Treatment
2003
Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories
2013 Standout
Treatment of Atrial Fibrillation by the Ablation of Localized Sources
2012
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score
2013
TGFβ and BMP signaling in cardiac cushion formation: Lessons from mice and chicken
2012
Elevated body mass index and mortality risk in the elderly
2006
Clinical Characteristics and Cardiovascular Magnetic Resonance Findings in Stress (Takotsubo) Cardiomyopathy
2011 Standout
Weight Loss Intervention for Obese Older Women: Improvements in Performance and Function
2004
QRS Fragmentation and the Risk of Sudden Cardiac Death in MADIT II
2012
Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
2010
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
Heart rate dynamics distinguish among atrial fibrillation, normal sinus rhythm and sinus rhythm with frequent ectopy
2015
Role of obstructive sleep apnea in cardiovascular disease
2011
Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome
2008
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Weight Loss on the Web: A Pilot Study Comparing a Structured Behavioral Intervention to a Commercial Program
2007
A Systematic Review of Randomized Trials Comparing Radiofrequency Ablation with Antiarrhythmic Medications in Patients with Atrial Fibrillation
2008
Dose‐Dependent Effects of Training and Detraining on Weight in 6406 Runners during 7.4 Years
2006
A Randomized Trial to Assess Catheter Ablation Versus Rate Control in the Management of Persistent Atrial Fibrillation in Heart Failure
2013
A Simplified Approach to the Management of Non–ST-Segment Elevation Acute Coronary Syndromes
2005
A Randomized Controlled Trial of a Commercial Internet Weight Loss Program
2004
‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
2013 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
MRI in acute myocardial infarction
2010
Sensors and regulators of intracellular pH
2009 Standout
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
2009 Standout
Right Atrial Focal Atrial Fibrillation
1999
Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation
2012
Ghrelin: Structure and Function
2005 Standout
Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance Heralds an Adverse Prognosis in Nonischemic Cardiomyopathy
2008
Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome
2007
Management of atrial fibrillation in patients with heart failure
2006
A Family‐Based Approach to Preventing Excessive Weight Gain
2006
Identifying the Energy Gap: Magnitude and Determinants of 5‐Year Weight Gain in Midage Women
2005
Physician Competencies for Prescribing Lifestyle Medicine
2010 Standout
Physical Activity Patterns in the National Weight Control Registry
2008
Effect of Current and Midlife Obesity Status on Mortality Risk in the Elderly
2008
Quantitative Tissue Characterization of Infarct Core and Border Zone in Patients With Ischemic Cardiomyopathy by Magnetic Resonance Is Associated With Future Cardiovascular Events
2010
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
2010
Detection of Previously Undiagnosed Atrial Fibrillation in Patients With Stroke Risk Factors and Usefulness of Continuous Monitoring in Primary Stroke Prevention
2012
‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue
2016
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Genetic Basis of Thoracic Aortic Aneurysms and Dissections: Focus on Smooth Muscle Cell Contractile Dysfunction
2008
Risk Prediction Models for Mortality in Ambulatory Patients With Heart Failure
2013
Meta-Analysis of Bleeding Complications Associated With Cardiac Rhythm Device Implantation
2012
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Clinical Application of Cardiac CMR
2009
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Revisiting the diacylglycerol‐induced insulin resistance hypothesis
2012
Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes
2009
2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery
2014
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
2009
Regulation of cell survival by Na+/H+exchanger-1
2008
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome
2014
Long-Term Results of Catheter Ablation in Paroxysmal Atrial Fibrillation
2010
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Get with the guidelines for cardiovascular secondary prevention: pilot results.
2004
Outcomes of Medicare Beneficiaries Undergoing Catheter Ablation for Atrial Fibrillation
2012
Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism
2011 Science
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
2006 StandoutScience
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice
2011 Science
Incidence of Newly Detected Atrial Arrhythmias via Implantable Devices in Patients With a History of Thromboembolic Events
2010
Atrial fibrillation: cure or treat?
2009
Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on Research in Marfan Syndrome and Related Disorders
2008
Efficacy and Risk of Atrial Fibrillation Ablation Before 45 Years of Age
2010
Works of Alan Cheng being referenced
The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers and Arrhythmia Monitors: Facilities and Patient Management
2011
Automated detection and characterization of complex fractionated atrial electrograms in human left atrium during atrial fibrillation
2007
Dual Antiplatelet Therapy and Heparin “Bridging” Significantly Increase the Risk of Bleeding Complications After Pacemaker or Implantable Cardioverter-Defibrillator Device Implantation
2010
Complications arising from catheter ablation of atrial fibrillation: Temporal trends and predictors
2011
TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome
2004
Prediction of Mortality in Clinical Practice for Medicare Patients Undergoing Defibrillator Implantation for Primary Prevention of Sudden Cardiac Death
2012
Complications of Catheter Ablation for Atrial Fibrillation: Incidence and Predictors
2008
Effects of Surgical and Endoscopic Electrocautery on Modern‐Day Permanent Pacemaker and Implantable Cardioverter‐Defibrillator Systems
2008
A Prospective Study Evaluating the Role of Obesity and Obstructive Sleep Apnea for Outcomes After Catheter Ablation of Atrial Fibrillation
2009
Predictive value of obstructive sleep apnoea assessed by the Berlin Questionnaire for outcomes after the catheter ablation of atrial fibrillation
2009
Circumferential Ablation With Pulmonary Vein Isolation in Permanent Atrial Fibrillation
2007
Lipid Disorders
2001
ABCs of Cardiovascular Disease Risk Management
2001
Long-term single procedure efficacy of catheter ablation of atrial fibrillation
2006
Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: Findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD)
2014
Impact of Heart Rhythm Status on Registration Accuracy of the Left Atrium for Catheter Ablation of Atrial Fibrillation
2007
Long‐Term Safety and Efficacy of Circumferential Ablation with Pulmonary Vein Isolation
2006
The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers and Arrhythmia Monitors: Facilities and Patient Management: Executive Summary
2011
Incidence and Time Course of Early Recovery of Pulmonary Vein Conduction after Catheter Ablation of Atrial Fibrillation
2007
Dynamic Analysis of Cardiac Rhythms for Discriminating Atrial Fibrillation From Lethal Ventricular Arrhythmias
2013
Symptomatic and Asymptomatic Atrial Fibrillation in Patients Undergoing Radiofrequency Catheter Ablation
2006
Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients With Left Ventricular Dysfunction
2007
TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome
2004
Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: A randomized clinical trial
2010
Combined Cardiac Magnetic Resonance Imaging and C-Reactive Protein Levels Identify a Cohort at Low Risk for Defibrillator Firings and Death
2012